arrow
邱

邱海波 (Haibo Qiu)

Sun Yat-sen University Cancer Center
H指数:29
被引数:6,604

个人简介

"教育经历 2010.10-2012.09 哈佛大学医学院 联合培养博士生 2009.09-2013.06 中山大学 肿瘤学 博士 2006.09-2009.06 中山大学 肿瘤学 硕士 2001.09-2006.06 广州医学院 临床医学 本科 工作经历 2024.01-至今 中山大学肿瘤防治中心 胃外科 主任医师 2018.01-2023.12 中山大学肿瘤防治中心 胃外科 副主任医师 2016.01-2017.12 中山大学肿瘤防治中心 胃外科 主治医师 2013.08-2015.12 中山大学肿瘤防治中心 胃胰科 医师"

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial

中国晚期胃肠道间质瘤患者中瑞普替尼与舒尼替尼的长期结局:一项2期随机临床试验的更新分析

Cancer
IF5.1
2025-12-090
OAAI
Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational research

奥韦仑巴替尼(Olverembatinib),一种可调节脂质代谢的多靶点激酶抑制剂,在高级别琥珀酸脱氢酶缺陷型胃肠道间质瘤中的应用:一项1b期研究及转化医学研究

2025-11-040
OAAI
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA

INSPECTOR研究:基于酶辅助高信噪比测序甲基化循环肿瘤DNA的多癌种早期检测方法的临床转化可行性提升

2025-10-300
OAAI
Effect of Continuous High-Frequency Oscillation Therapy on Lung Aeration in Mechanically Ventilated Patients with Impaired Consciousness: A Multicenter Randomized Controlled Trial

连续高频振荡通气对意识障碍机械通气患者肺复张的影响:一项多中心随机对照试验

CHEST
IF8.6
2025-09-200
PREAI
Distinguishing very high-risk patients among high-risk gastrointestinal stromal tumor cases: development and validation of a nomogram based on a multicenter population-based retrospective cohort study

在高风险胃肠间质瘤病例中区分极高危患者的模型:一项基于多中心、基于人群的回顾性队列研究开发的列线图构建与验证

2025-06-200
OA
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial (vol 30, pg 552, 2024)

围手术期toripalimab和化疗治疗局部晚期胃癌或胃食管交界处癌: 一项随机2期试验 (第30卷,552页,2024)

2024-01-081
OA
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial

围手术期toripalimab和化疗治疗局部晚期胃癌或胃食管交界处癌: 一项随机2期试验

2024-01-0231
PRE
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
2024-01-014
PRE
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancer

辅助化疗后残留的循环肿瘤DNA能够有效预测II–III期胃癌的复发。

2023-10-144
OAAI